Cisplatin-etoposide alternating with topotecan in patients with extensive stage small cell lung cancer (SCLC). A multicenter phase II study. [electronic resource]
Producer: 20030415Description: 59-63 p. digitalISSN:- 0169-5002
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Small Cell -- drug therapy
- Cisplatin -- administration & dosage
- Disease Progression
- Drug Administration Schedule
- Etoposide -- administration & dosage
- Female
- Humans
- Infusions, Intravenous
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Neutropenia -- chemically induced
- Survival
- Thrombocytopenia -- chemically induced
- Topotecan -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.